Search This Blog

Thursday, November 3, 2022

Bausch Health trims guidance

 ausch Health updated its consolidated guidance for the full year 2022 as follows:

  • Full year revenue range of $8.0 - $8.17 billion compared with prior guidance of $8.05 - $8.22 billion

  • Full year revenues flat to up 2% on an organic basis (unchanged)

  • Full year Adjusted EBITDA (non-GAAP)1 range of $2.99 - $3.09 billion compared with prior guidance of $3.02 - $3.12 billion

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.